8 CRR-NY 52.39NY-CRR
8 CRR-NY 52.39
8 CRR-NY 52.39
52.39 Cytotechnology.
In addition to meeting all applicable provisions of this Part, to be registered as a program recognized as leading to licensure as a cytotechnologist, which meets the requirements of section 79-14.1 of this Title, the program shall:
(a) be a program in cytotechnology leading to a baccalaureate or higher degree or advanced certificate which contains didactic and clinical education that integrates pre-analytical, analytical, and post-analytical components of laboratory services, including the principles and practices of quality assurance/quality improvement; and which is designed to prepare graduates to practice cytotechnology using independent judgment and responsibility;
(b) include coursework, which shall include a laboratory component in each area, in each of the following subject areas or their equivalent as determined by the department:
(1) inorganic chemistry;
(2) anatomy and physiology;
(3) cell biology;
(4) cytopathology, including but not limited to, female genital tract, respiratory tract, gastro-intestinal and genitourinary tracts, body fluids, evaluation of specimens from washes and brushes of all body sites, and evaluation of specimens from fine needle aspiration biopsies of all body sites;
(5) cytopreparatory techniques, including but not limited to, preparation, staining and processing of body samples; and
(6) microscopic evaluation and interpretation of cytopathology of the sample types and body systems identified in paragraph (4) of this subdivision;
(c) include curricular content in each of the following subject areas or their equivalent as determined by the department:
(1) organic chemistry;
(2) mathematics and statistics;
(3) infection control and universal precautions (standard precautions);
(4) human genetics;
(5) immunology;
(6) clinical microbiology;
(7) the maintenance of equipment and records; and
(8) ethics; and
(d) include a supervised clinical experience of at least 30 hours per week for at least 10 weeks or its equivalent as determined by the department, in the practice of cytotechnology.
8 CRR-NY 52.39
Current through August 15, 2021
| End of Document |